←
Loading live data…
PRICE
Loading…
REVENUE MIX
Total Revenue100%
COST
COGS44%
R&D + SG&A39%
Op Margin17%
FINANCIAL HEALTH
REVENUE
$41.3B
Growth
50%
Gross M.
56%
P/E
123.4
EV/EBITDA
78.7
Net M.
16%
FCF M.
21%
D/E
0.05
Op M.
17%
PLUG INTO YOUR DCF
Historical growth
28.8%
Analyst 5y growth
—
Forward P/E
30.2
PEG ratio
1.10
Trailing EPS
$3.80
Forward EPS
$15.50
🚩 RED FLAG SCANNER — 10-K RISK FACTORS, YEAR OVER YEAR
TAM
SIZE
—
CAGR
—
Market-size estimates aren't available for this stock right now — see Financial Health and Risk Assessment below for a fundamentals-based read instead.
RISK ASSESSMENT
HIGTrading above a mechanical base-case DCF estimate of $250.69 (default assumptions) — priced for continued strong execution.
LOWDebt/equity of 0.05 — conservative balance sheet.
MEDRevenue growing 50% YoY — the multiple depends on this pace continuing; deceleration is a real risk.
🐂 BULL
AMD shows revenue grew +50.1% YoY, 17% operating margin, 10% ROE, a healthy 21% free cash flow margin — a business converting growth into real profit.
🐻 BEAR
At a P/E of 123.4 and EV/EBITDA of 78.7, the stock is priced for continued execution — any deceleration in growth or margin compression would likely pressure the multiple.
AI-powered data, computed by TreasureX · May contain inaccuracies
⚠️
All values, scores, and figures here are computed from your own assumptions and public data, for educational purposes only. This is not investment advice — TreasureX does not recommend buying or selling any security. Results change with your inputs. Please do your own research and use your own judgement before making any investment decision.